Shares of Tristel plc (LON:TSTL – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 505.45 ($6.54) and last traded at GBX 499.25 ($6.46), with a volume of 202329 shares. The stock had previously closed at GBX 490 ($6.34).
Tristel Stock Performance
The stock has a market capitalization of £227.00 million, a P/E ratio of 3,692.31 and a beta of 0.26. The firm has a 50-day moving average of GBX 446.84 and a 200 day moving average of GBX 452.98. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12.
Insider Buying and Selling
In other Tristel news, insider Elizabeth Dixon sold 29,000 shares of Tristel stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of GBX 440 ($5.69), for a total transaction of £127,600 ($165,028.45). 5.29% of the stock is owned by company insiders.
Tristel Company Profile
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Featured Articles
- Five stocks we like better than Tristel
- About the Markup Calculator
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Options Trading – Understanding Strike Price
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with MarketBeat.com's FREE daily email newsletter.